Glycosylation, Macrophage migration inhibitory factor-like MIF2
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 4 |
Pissara et al. | yes | yes: 28 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005615 | extracellular space | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A0A3S7X6W1
PDB structure(s): 3b64_A , 3fwt_A , 3fwu_A , 4nwr_1 , 4nwr_3 , 4nwr_5 , 4nwr_7 , 4nwr_9 , 4nwr_AB , 4nwr_AD , 4nwr_AF , 4nwr_AH , 4nwr_AJ , 4nwr_AL , 4nwr_AN , 4nwr_AP , 4nwr_AR , 4nwr_AT , 4nwr_AV , 4nwr_AX , 4nwr_AZ , 4nwr_b , 4nwr_BB , 4nwr_BD , 4nwr_BF , 4nwr_BH , 4nwr_d , 4nwr_f , 4nwr_h , 4nwr_j , 4nwr_l , 4nwr_n , 4nwr_p , 4nwr_r , 4nwr_t , 4nwr_v , 4nwr_x , 4nwr_z
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0016853 | isomerase activity | 2 | 2 |
GO:0016860 | intramolecular oxidoreductase activity | 3 | 2 |
GO:0016862 | intramolecular oxidoreductase activity, interconverting keto- and enol-groups | 4 | 2 |
GO:0050178 | phenylpyruvate tautomerase activity | 5 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.476 |
CLV_PCSK_PC1ET2_1 | 16 | 18 | PF00082 | 0.476 |
CLV_PCSK_SKI1_1 | 75 | 79 | PF00082 | 0.426 |
DEG_SCF_FBW7_1 | 76 | 82 | PF00400 | 0.297 |
DOC_CKS1_1 | 76 | 81 | PF01111 | 0.382 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.404 |
DOC_WW_Pin1_4 | 75 | 80 | PF00397 | 0.351 |
LIG_14-3-3_CanoR_1 | 17 | 27 | PF00244 | 0.468 |
LIG_FHA_1 | 76 | 82 | PF00498 | 0.404 |
LIG_LIR_Nem_3 | 21 | 27 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 64 | 69 | PF02991 | 0.415 |
LIG_LIR_Nem_3 | 94 | 100 | PF02991 | 0.552 |
LIG_SH2_CRK | 24 | 28 | PF00017 | 0.564 |
LIG_SH2_PTP2 | 60 | 63 | PF00017 | 0.456 |
LIG_SH2_SRC | 69 | 72 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.456 |
LIG_SH2_STAT5 | 97 | 100 | PF00017 | 0.398 |
LIG_SH3_3 | 68 | 74 | PF00018 | 0.404 |
LIG_SUMO_SIM_par_1 | 6 | 11 | PF11976 | 0.435 |
LIG_TYR_ITSM | 20 | 27 | PF00017 | 0.399 |
MOD_CDK_SPK_2 | 75 | 80 | PF00069 | 0.382 |
MOD_CK1_1 | 44 | 50 | PF00069 | 0.382 |
MOD_GlcNHglycan | 81 | 84 | PF01048 | 0.340 |
MOD_GSK3_1 | 47 | 54 | PF00069 | 0.382 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.382 |
MOD_N-GLC_1 | 18 | 23 | PF02516 | 0.415 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.396 |
MOD_NEK2_1 | 38 | 43 | PF00069 | 0.374 |
MOD_NEK2_1 | 51 | 56 | PF00069 | 0.391 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.386 |
MOD_PKA_2 | 79 | 85 | PF00069 | 0.299 |
MOD_Plk_4 | 3 | 9 | PF00069 | 0.541 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.404 |
MOD_ProDKin_1 | 75 | 81 | PF00069 | 0.351 |
MOD_SUMO_rev_2 | 9 | 18 | PF00179 | 0.459 |
TRG_ENDOCYTIC_2 | 24 | 27 | PF00928 | 0.653 |
TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.468 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I920 | Leptomonas seymouri | 65% | 100% |
A0A3S7X6S3 | Leishmania donovani | 60% | 100% |
A4I970 | Leishmania infantum | 60% | 100% |
A4I971 | Leishmania infantum | 100% | 100% |
A9JSE7 | Xenopus tropicalis | 26% | 98% |
E9B411 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 61% | 100% |
E9B412 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
P81529 | Trichinella spiralis | 27% | 99% |
Q4Q412 | Leishmania major | 94% | 100% |
Q4Q413 | Leishmania major | 59% | 100% |
Q76BK2 | Xenopus laevis | 29% | 98% |